 |
市场调查报告书
商品编码
1477268
局部给药市场，依配方、依给药途径、依配销通路、地理位置Topical Drug Delivery Market, By Formulation, By Route of Administration, By Distribution Channel, By Geography |
||||||
预计2024年外用给药市值为1,249亿美元，预计2031年将达2,299.1亿美元，2024年至2031年的年复合成长率（CAGR）为9.1%。
| 报告范围 | 报告详情 | ||
|---|---|---|---|
| 基准年： | 2023年 | 2024 年市场规模： | 1,249亿美元 |
| 历史数据： | 2019年至2023年 | 预测期： | 2024年至2031年 |
| 预测 2024 年至 2031 年复合年增长率： | 9.10% | 2031 年价值预测： | 2299.1 亿美元 |
局部药物递送是指将治疗化合物直接施用到作用部位。这种局部药物传输旨在最大限度地提高治疗效果，同时最大限度地减少全身副作用。它涉及将凝胶、霜剂、泡沫、薄膜等製剂应用于皮肤或黏膜表面。与全身给药相比，局部给药可以以较低的总剂量在目标组织中提供更高的药物浓度。这提高了功效和安全性。对疼痛管理和皮肤病治疗的需求不断增长是推动人们对局部给药方式产生兴趣的一个主要因素。
市场动态：
易患各种疾病的老年人口不断增加、皮肤病和眼科疾病患病率上升以及对疼痛管理疗法的需求不断增加，推动了局部给药市场的发展。然而，由于角质层等生物屏障导致的药物渗透问题构成了挑战。从积极的一面来看，奈米载体、脂质系统和新型聚合物等配方技术的不断进步正在扩大可能性并改善渗透性。新兴经济体不断增长的医疗支出也带来了机会。近年来，局部给药市场取得了显着的技术进步。新的创新旨在增强药物输送的皮肤渗透性，同时提高治疗效果和患者舒适度。一个关键趋势是奈米级输送系统的发展。奈米颗粒配方可以帮助药物渗透到皮肤更深层。这克服了治疗皮肤病的主要障碍。脂质体、聚合物奈米粒子、树枝状聚合物和奈米乳液都在透皮递送方面显示出前景。研究人员正在探索优化颗粒大小、成分和表面电荷的方法，以最大限度地提高皮肤渗透性。
研究的主要特点：
- 该报告对全球局部给药市场进行了深入分析，并提供了以2023年为基准年的预测期（2024-2031年）的市场规模（十亿美元）和年复合成长率（CAGR%）。
- 它阐明了不同细分市场的潜在收入成长机会，并解释了该市场有吸引力的投资主张矩阵。
- 这项研究还提供了有关市场驱动因素、限制因素、机会、新产品发布或批准、市场趋势、区域前景以及主要参与者采取的竞争策略的重要见解。
- 它根据以下参数描述了全球局部给药市场的主要参与者——公司亮点、产品组合、主要亮点、财务表现和策略。
- 该报告的见解将使行销人员和公司管理当局能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
- 全球局部给药市场报告迎合了该行业的各个利益相关者，包括投资者、供应商、产品製造商、分销商、新进业者和财务分析师。
- 利害关係人可以透过用于分析全球局部给药市场的各种策略矩阵轻鬆做出决策。
目录
第一章：研究目标与假设
- 研究目标
- 假设
- 缩写
第 2 章：市场范围
- 报告说明
- 市场定义和范围
- 执行摘要
- Coherent Opportunity Map (COM)
第 3 章：市场动态、法规与趋势分析
- 市场动态
- 司机
- 限制
- 机会
- 影响分析
- 市场走向
- 最近的发展
- 收购和合作场景
- 技术概览
- 监管场景
- 定价分析
- PEST分析
第 4 章：全球局部给药市场 - 冠状病毒 (COVID-19) 大流行的影响
- 整体影响
- 政府倡议
- COVID-19 对市场的影响
第 5 章：2019 - 2031 年全球外用药物输送市场（按配方）（十亿美元）
- 概述
- 液体配方
- 半固体製剂
- 固体製剂
- 透皮贴剂
第 6 章：2019 - 2031 年全球局部给药市场（依给药途径）（十亿美元）
- 概述
- 真皮
- 直肠
- 阴道
- 其他的
第 7 章：全球外用药物输送市场，按配销通路，2019 - 2031 年（十亿美元）
- 概述
- 医院药房
- 零售药局
- 网路药局
第 8 章：2019 - 2031 年全球局部给药市场（按地区）（十亿美元）
- 介绍
- 北美洲
- 我们
- 加拿大
- 拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 拉丁美洲其他地区
- 欧洲
- 英国
- 德国
- 义大利
- 法国
- 西班牙
- 俄罗斯
- 欧洲其他地区
- 亚太地区
- 中国
- 印度
- 日本
- 东协
- 澳洲
- 韩国
- 亚太地区其他地区
- 中东
- 海湾合作委员会
- 以色列
- 中东其他地区
- 非洲
- 北非
- 中非
- 南非
第 9 章：竞争格局
- 公司简介
- Johnson & Johnson
- Pfizer Inc.
- Novartis International AG
- GSK plc
- Bayer AG
- Merck & Co., Inc.
- Sanofi
- Teva Pharmaceutical Industries Ltd.
- AbbVie Inc.
- Eli Lilly and Company
- Galderma Laboratories, LP
- Viatris Inc.
- Sun Pharmaceutical Industries Ltd.
- Perrigo Company plc
- Bausch Health Companies Inc.
- Taro Pharmaceutical Industries Ltd.
- Glenmark Pharmaceuticals Ltd.
- Almirall SA
第 10 章：分析师观点
- 命运之轮
- 分析师观点
- 连贯的机会图
第 11 章：参考文献与研究方法
- 参考
- 研究方法论
The topical drug delivery market is estimated to be valued at USD 124.90 Bn in 2024 and is expected to reach USD 229.91 Bn by 2031, growing at a compound annual growth rate (CAGR) of 9.1% from 2024 to 2031.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2023 | Market Size in 2024: | US$ 124.90 Bn |
| Historical Data for: | 2019 To 2023 | Forecast Period: | 2024 To 2031 |
| Forecast Period 2024 to 2031 CAGR: | 9.10% | 2031 Value Projection: | US$ 229.91 Bn |
Topical drug delivery refers to the administration of therapeutic compounds directly to the site of action. This localized drug delivery aims to maximize the therapeutic effects while minimizing the systemic side effects. It involves the application of formulations like gels, creams, foams, films, etc. to the skin or mucosal surfaces. Compared to systemic delivery, topical drug administration allows higher drug concentration in the targeted tissue with lower overall doses. This enhances efficacy and safety. The growing demand for pain management and dermatological therapies is a major factor driving interest in topical delivery modalities.
Market Dynamics:
The topical drug delivery market is driven by the growing geriatric population susceptible to various diseases, rising prevalence of dermatological and ophthalmic conditions, and increasing demand for pain management therapies. However, drug permeation issues owing to biological barriers like stratum corneum pose a challenge. On the positive side, ongoing advancements in formulation technologies like nanocarriers, lipid-based systems, and novel polymers are expanding the possibilities and improving permeation. Growing healthcare expenditure in emerging economies also opens up opportunities. The topical drug delivery market has seen significant technological advancements in recent years. New innovations aim to enhance skin permeability for drug delivery while also improving treatment efficacy and patient comfort. One key trend is the development of nano-scale delivery systems. Nanoparticle formulations can help medications penetrate deeper layers of the skin. This overcomes a major barrier for treating dermatological conditions. Liposomes, polymeric nanoparticles, dendrimers, and nano emulsions have all shown promise in transdermal delivery. Researchers are exploring ways to optimize particle size, composition, and surface charge to maximize skin permeation.
Key Features of the Study:
- This report provides an in-depth analysis of the global topical drug delivery market, and provides market size (USD BN) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
- It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global topical drug delivery market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study includes Johnson & Johnson, Pfizer Inc., Novartis International AG, GSK plc, Bayer AG, Merck & Co., Inc., Sanofi, Teva Pharmaceutical Industries Ltd., AbbVie Inc., Eli Lilly and Company, Galderma Laboratories, L.P., Viatris Inc., Sun Pharmaceutical Industries Ltd., Perrigo Company plc, Bausch Health Companies Inc., Taro Pharmaceutical Industries Ltd., Glenmark Pharmaceuticals Ltd., and Almirall S.A.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global topical drug delivery market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global topical drug delivery market
Market Segmentation
- By Formulation:
- Liquid Formulations
- Semi-Solid Formulations
- Solid Formulations
- Transdermal Patches
- By Route of Administration:
- Dermal
- Rectal
- Vaginal
- Others
- By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
- Company Profiles:
- Johnson & Johnson
- Pfizer Inc.
- Novartis International AG
- GSK plc
- Bayer AG
- Merck & Co., Inc.
- Sanofi
- Teva Pharmaceutical Industries Ltd.
- AbbVie Inc.
- Eli Lilly and Company
- Galderma Laboratories, L.P.
- Viatris Inc.
- Sun Pharmaceutical Industries Ltd.
- Perrigo Company plc
- Bausch Health Companies Inc.
- Taro Pharmaceutical Industries Ltd.
- Glenmark Pharmaceuticals Ltd.
- Almirall S.A.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Formulation
- Market Snapshot, By Route of Administration
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Opportunities
- Impact Analysis
- Market Trends
- Recent Developments
- Acquisitions and Partnership Scenario
- Technology Overview
- Regulatory Scenario
- Pricing Analysis
- PEST Analysis
4. Global Topical Drug Delivery Market - Impact of Coronavirus (COVID-19) Pandemic
- Overall Impact
- Government Initiatives
- COVID-19 impact on the market
5. Global Topical Drug Delivery Market, By Formulation, 2019 - 2031, (USD BN)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Liquid Formulations
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)
- Semi-Solid Formulations
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)
- Solid Formulations
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)
- Transdermal Patches
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)
6. Global Topical Drug Delivery Market, By Route of Administration, 2019 - 2031, (USD BN)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Dermal
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)
- Rectal
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)
- Vaginal
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)
7. Global Topical Drug Delivery Market, By Distribution Channel, 2019 - 2031, (USD BN)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Hospital Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)
- Retail Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)
- Online Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)
8. Global Topical Drug Delivery Market, By Region, 2019 - 2031, (USD BN)
- Introduction
- Market Share Analysis, By Region, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, For Region, 2020-2031
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD BN)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD BN)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD BN)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD BN)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD BN)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD BN)
- North Africa
- Central Africa
- South Africa
9. Competitive Landscape
- Company Profiles
- Johnson & Johnson*
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Pfizer Inc.
- Novartis International AG
- GSK plc
- Bayer AG
- Merck & Co., Inc.
- Sanofi
- Teva Pharmaceutical Industries Ltd.
- AbbVie Inc.
- Eli Lilly and Company
- Galderma Laboratories, L.P.
- Viatris Inc.
- Sun Pharmaceutical Industries Ltd.
- Perrigo Company plc
- Bausch Health Companies Inc.
- Taro Pharmaceutical Industries Ltd.
- Glenmark Pharmaceuticals Ltd.
- Almirall S.A.
10. Analyst View
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
11. References and Research Methodology
- References
- Research Methodology
- About us and Sales Contact
